Supplements

Supplement: Extended Depth of Focuswith the Bi-Flex ELON IOL

Empowered by Wavefront Linking technologyfor an elongated depth of field

Supplement: Extended Depth of Focuswith the Bi-Flex ELON IOL

Non-diffractive Extended Depth of Focus (EDoF) IOLs represent the latest generation of presbyopia-correcting IOLs. Using various physical or optical principles, these lenses aim to satisfy patients’ visual needs with an active lifestyle while minimizing the risk of dysphotopsia compared to diffractive technologies. This article introduces Medicontur’s latest innovation, the ELON IOL, as a new option within the non-diffractive EDoF IOL category. The article describes ELON’s proprietary Wavefront Linking technology that is designed to create a true ELONgated Focus and presents the first clinical experiences of ELON users.

Tags: cataract and refractive
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...